Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957

Watchlist Manager
Yunnan Botanee Bio-Technology Group Co Ltd Logo
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Watchlist
Price: 50.72 CNY -4.91% Market Closed
Market Cap: 21.3B CNY
Have any thoughts about
Yunnan Botanee Bio-Technology Group Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Yunnan Botanee Bio-Technology Group Co Ltd

Wall Street analysts forecast Yunnan Botanee Bio-Technology Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Yunnan Botanee Bio-Technology Group Co Ltd is 67.05 CNY with a low forecast of 43.43 CNY and a high forecast of 114.45 CNY.

Lowest
Price Target
43.43 CNY
14% Downside
Average
Price Target
67.05 CNY
32% Upside
Highest
Price Target
114.45 CNY
126% Upside
Yunnan Botanee Bio-Technology Group Co Ltd Competitors:
Price Targets
DDD
Do Day Dream PCL
2% Downside
SIS
Science in Sport PLC
18% Upside
DABUR
Dabur India Ltd
32% Upside
USNA
USANA Health Sciences Inc
24% Upside
4931
Shinnihonseiyaku Co Ltd
4% Downside
4919
Milbon Co Ltd
16% Upside
603868
Shanghai Flyco Electrical Appliance Co Ltd
37% Upside
MED
Medifast Inc
6% Downside

Revenue
Forecast

Revenue Estimate
Yunnan Botanee Bio-Technology Group Co Ltd

For the last 5 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's revenue is 35%. The projected CAGR for the next 3 years is 15%.

35%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Yunnan Botanee Bio-Technology Group Co Ltd

For the last 5 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 18%.

21%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Yunnan Botanee Bio-Technology Group Co Ltd

For the last 5 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 17%.

24%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Yunnan Botanee Bio-Technology Group Co Ltd's stock price target?
Price Target
67.05 CNY

According to Wall Street analysts, the average 1-year price target for Yunnan Botanee Bio-Technology Group Co Ltd is 67.05 CNY with a low forecast of 43.43 CNY and a high forecast of 114.45 CNY.

What is Yunnan Botanee Bio-Technology Group Co Ltd's Revenue forecast?
Projected CAGR
15%

For the last 5 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's revenue is 35%. The projected CAGR for the next 3 years is 15%.

What is Yunnan Botanee Bio-Technology Group Co Ltd's Operating Income forecast?
Projected CAGR
18%

For the last 5 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 18%.

What is Yunnan Botanee Bio-Technology Group Co Ltd's Net Income forecast?
Projected CAGR
17%

For the last 5 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 17%.

Back to Top